In The Spotlight
Coriell, U.S. Air Force Authors Collaborate on Publication (January 2017)
Coriell's Dr. Michael Christman Receives Research Award (October 2016)Read More News
Making Medicine Personalized for You
Our health is determined by many factors: the genetics we inherit; our innate personal traits of race, age and gender; our individual behavior; our family and community networks; and at the macro level, our economic, cultural, and environmental conditions. These factors are different for every person and will change over their lifespan. So too is a person’s experience with disease and how they respond to drugs or other medical interventions. Personalized medicine intends to make medical treatment as individual as the biology of one’s disease.
Personalized medicine has the potential to offer patients and their doctors several advantages, including:
- The ability to make better informed clinical decisions.
- A higher probability of desired health outcomes by using better-targeted therapies.
- The reduced probability of adverse reactions from medications and treatments.
- A focus on prevention and prediction of disease, rather than reaction to it.
- Earlier disease intervention.
- Reduced healthcare costs.
Coriell Institute for Medical Research is recognized as a leader in the emerging field of personalized medicine. The Coriell Personalized Medicine Collaborative® (CPMC®) is a forward-looking research study designed to understand the usefulness of personal genetic risk and pharmacogenomic information (the influence of genetic variation on drug response) in health management and clinical decision-making. More than 8,500 research study participants are currently receiving personalized genetic risk results from our study.
Recognizing the importance of educating the medical and lay communities about genetics and its usefulness in medicine, we lecture to medical students, physicians, and other healthcare providers about the value of personalized medicine.
We ultimately believe that the success of personalized medicine depends on its ability to demonstrate its value to the healthcare system, to the industries that develop its products, and to patients. The CPMC research study is striving to be a model for the ethical, legal, and responsible implementation of best practices in personalized medicine.
What is Personalized Medicine?
When test your genetic information informs your increased risk for a disease and you make lifestyle changes to reduce that risk, personalized medicine has revealed itself. [ Learn More › ]
DNA, Genes, and SNPs
The human body is composed of trillions of cells – cells being the building blocks of all living things. [ Learn More › ]
What is the CPMC Study?
The Coriell Personalized Medicine Collaborative® (CPMC®) is a research study that employs an evidence-based approach to determine the utility of using personal genome information in health management and clinical decision-making. [ Learn More › ]
Meeting the Data Challenge [ Learn More › ]
CPMC Advisors and Partners
Coriell Institute counts many well-respected institutions and advisors as partners in research. [ Learn More › ]
Coriell Life Sciences
Meet our Team
Click here to meet our leadership and scientific staff.